Clinic
Community Quick Care of Lavergne, PC
Community Quick Care of Lavergne, PC was paid $3.34M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoCOMMUNITY QUICK CARE OF LAVERGNE, PC
LA VERGNE, TN 37086
LA VERGNE, TN 37086
33aNPI1194023366assigned 03/11/2011
33bProvider typeUrgent Care Clinic/Center
28Total paid$3.34M
24GClaims135,634
24DCodes billed80
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Tennessee
Rank by total paid#4 of 38
Median peer was paid$345K
This provider vs. median9.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,044 | $422K | |
| 2019 | 22,065 | $326K | |
| 2020 | 18,469 | $384K | |
| 2021 | 23,118 | $644K | |
| 2022 | 25,606 | $704K | |
| 2023 | 20,914 | $550K | |
| 2024incomplete | 10,418 | $311K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 24,503 | 20,827 | $1.19M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 17,684 | 15,516 | $619K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.5% | 7,037 | 6,189 | $316K |
| 99348 | 7.8% | 4,919 | 2,792 | $262K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.7% | 3,545 | 3,048 | $190K |
| 99384 | 3.9% | 1,744 | 1,480 | $131K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.2% | 937 | 770 | $74K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 4,980 | 4,056 | $74K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.1% | 3,879 | 2,918 | $70K |
| 99349 | 2.0% | 839 | 551 | $67K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.3% | 1,326 | 1,036 | $42K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 448 | 395 | $33K |
68 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 965 | $32K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,441 | $29K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 273 | $28K |
| 99347 | <1% | 760 | $26K | |
| 96136 | <1% | 769 | $23K | |
| 99173 | <1% | 2,794 | $20K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,000 | $19K |
| 86580 | <1% | 2,281 | $14K | |
| 80305 | <1% | 1,250 | $8K | |
| 81002 | <1% | 4,087 | $8K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 63 | $8K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 269 | $7K |
| 87428 | <1% | 147 | $7K | |
| 92552 | <1% | 473 | $6K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 66 | $5K |
| 96103 | <1% | 246 | $3K | |
| 95923 | <1% | 39 | $3K | |
| 99383 | <1% | 32 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 28 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,979 | $2K |
| 81025 | <1% | 370 | $2K | |
| 93922 | <1% | 24 | $2K | |
| 96127 | <1% | 386 | $1K | |
| 96160 | <1% | 77 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 15 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 156 | $1K |
| 81003 | <1% | 1,004 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 15 | $1K |
| 95943 | <1% | 28 | $794.91 | |
| 90686 | <1% | 147 | $785.28 | |
| 96146 | <1% | 653 | $698.68 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 400 | $619.63 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 28 | $581.26 |
| 1159F | <1% | 5,816 | $500.00 | |
| 95117 | <1% | 45 | $493.60 | |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | <1% | 719 | $438.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 19 | $392.23 |
| 92587 | <1% | 17 | $316.97 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 77 | $282.64 |
| 90674 | <1% | 12 | $158.82 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 66 | $103.49 |
| 99051 | <1% | 47 | $101.43 | |
| 99406 | <1% | 12 | $89.61 | |
| 3008F | <1% | 6,391 | $80.00 | |
| 3079F | <1% | 162 | $30.00 | |
| 90461 | <1% | 117 | $22.87 | |
| 3074F | <1% | 246 | $20.00 | |
| 3077F | <1% | 26 | $20.00 | |
| 3080F | <1% | 14 | $10.00 | |
| 3078F | <1% | 103 | $10.00 | |
| 99070 | <1% | 111 | $4.80 | |
| 99000 | <1% | 11,355 | $4.32 | |
| 1036F | 0% | 3,485 | $0.00 | |
| 3075F | 0% | 13 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 68 | $0.00 |
| 1034F | 0% | 48 | $0.00 | |
| 4000F | 0% | 15 | $0.00 | |
| 1126F | 0% | 19 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 859 | $0.00 |
| 3725F | 0% | 120 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 371 | $0.00 |
| 90715 | 0% | 29 | $0.00 | |
| 90734 | 0% | 39 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 22 | $0.00 |
| 90649 | 0% | 24 | $0.00 | |
| 4035F | 0% | 15 | $0.00 | |
| 4004F | 0% | 12 | $0.00 | |
| 1160F | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialELEDGE, JERRY (CEO)